Yes, Johnson & Johnson (NYSE: JNJ) is widely recognized as an exceptional dividend payer. It belongs to the elite group of "Dividend Kings," having increased its regular cash dividend payout for over 60 consecutive years. Its strong balance sheet, defensive healthcare business model, and reliable cash flows make it a foundational holding for income-focused and long-term retirement portfolios.